Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adapalene/BPO Gel in Dark Skin Acne
NCT02932267Phase 3Completed
- Sponsor
- Galderma
- Start
- Feb 2017
- Primary completion
- Jan 2018
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of adapalene + benzoyl peroxide in acne vulgaris, sponsored by Galderma. Started Feb 2017; status: completed.
02
Drugs
adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02932267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02932267.